Learn More


 
MBA Tools
MBA Glossary

 


Salix Pharmaceuticals, Ltd. - SLXP - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

 

Salix Pharmaceuticals, Ltd. - SIC # 2834

Ticker Exchange SIC # Website Latest Ticker
SLXP Nasdaq 2834 http://www.salix.com 59.41 Stock Up +0.13

Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company:

Latest Headlines for Salix Pharmaceuticals, Ltd.

FDA Accepts Actavis NDA - May 20th, 2013 9:00 am
SALIX PHARMACEUTICALS LTD Financials - May 17th, 2013 11:04 am
Good News for Roche's Tarceva - May 16th, 2013 4:00 pm
Good News for Novartis' Ilaris - May 15th, 2013 3:16 pm
FDA Accepts Merck BLA - May 15th, 2013 9:10 am
Salix Stock Hits New 52-Week High (SLXP) - May 15th, 2013 7:55 am
Salix Beats on Earnings - May 14th, 2013 7:45 am


View All Current Headlines >>

Bookmark and Share
facebooktwitter